SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-053619
Filing Date
2023-10-16
Accepted
2023-10-16 20:06:20
Documents
1
Period of Report
2023-08-31

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3886
  Complete submission text file 0000950170-23-053619.txt   5331
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Issuer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CATALYST BIOSCIENCES, INC. 611 GATEWAY BOULEVARD, SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address
Ling Geoffrey M.D. (Reporting) CIK: 0001800097 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38914 | Film No.: 231328274